Cost-benefit and cost-effectiveness analysis of drug abuse treatment services.
- 1 October 1998
- journal article
- research article
- Published by SAGE Publications in Evaluation Review
- Vol. 22 (5) , 609-636
- https://doi.org/10.1177/0193841x9802200503
Abstract
The foundations of cost-benefit analysis and cost-effectiveness analysis (CB/CEA) for drug abuse treatment are developect An economic model of addict choice and drug markets is presented. This model is synthesized with the current "cost of illness" methods used to measure the burden of the disease to society. The problem of doing cost-effectiveness studies in the presence of large nonhealth benefits is examined, and guidance is offered to clinical studies with a cost-effectiveness component or to stand-alone cost-effectiveness studies. References and an extensive bibliography on drug abuse treatment-related CB/CEA studies are appended.Keywords
This publication has 17 references indexed in Scilit:
- Service-Level Costing of Drug Abuse TreatmentJournal of Substance Abuse Treatment, 1998
- Letter: Estimating the economic cost of substance abuse treatmentHealth Economics, 1997
- The costs of drug abuse consequences: A summary of research findingsJournal of Substance Abuse Treatment, 1996
- Estimating the Dollar Value of Health Outcomes from Drug-Abuse InterventionsMedical Care, 1996
- Evaluating Health RisksPublished by Cambridge University Press (CUP) ,1995
- Statistical issues in cost–effectiveness analysesPublished by Cambridge University Press (CUP) ,1995
- Effectiveness and Costs of Inpatient versus Day Hospital Cocaine RehabilitationJournal of Nervous & Mental Disease, 1994
- Consequences and costs of shutting off methadoneAddictive Behaviors, 1989
- The Costs of Crime and the Benefits of Drug Abuse Treatment: A Cost- Benefit Analysis Using TOPS DataPublished by American Psychological Association (APA) ,1988
- Crime and Punishment: An Economic ApproachJournal of Political Economy, 1968